Why the study?
Does intravenous glutathione prevent hyperglycemia-induced thrombin formation in type II diabetic patients and healthy subjects?
Population
16 subjects (9 type II diabetic patients and 7 healthy control subjects matched for age and body mass index)
Comparison
Oral glucose tolerance test, intravenous… vs Healthy controls; and comparison between…
Design
Other
Follow-up
180 minutes
Authors
Loading...
GSH may blunt hyperglycemia-induced thrombin generation in diabetes; hypothesis-generating and requires randomized confirmation before practice change.
Does intravenous glutathione prevent hyperglycemia-induced thrombin formation in type II diabetic patients and healthy subjects?
Intravenous glutathione prevents hyperglycemia-induced thrombin generation, suggesting oxidative stress mediates coagulation activation in diabetes.
Ceriello et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: